News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,059 Results
Type
Article (12285)
Company Profile (122)
Press Release (212646)
Multimedia
Podcasts (8)
Webinars (10)
Section
Business (59939)
Career Advice (417)
Deals (9311)
Drug Delivery (26)
Drug Development (30911)
Employer Resources (43)
FDA (3810)
Job Trends (4903)
News (102301)
Policy (8221)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (982)
Accelerated approval (12)
Adcomms (5)
Allergies (45)
Alliances (16890)
ALS (61)
Alzheimer's disease (611)
Antibody-drug conjugate (ADC) (112)
Approvals (3909)
Artificial intelligence (172)
Autoimmune disease (69)
Automation (13)
Bankruptcy (70)
Best Places to Work (4184)
BIOSECURE Act (14)
Biosimilars (37)
Biotechnology (95)
Bladder cancer (57)
Brain cancer (21)
Breast cancer (223)
Cancer (1830)
Cardiovascular disease (72)
Career advice (387)
Career pathing (8)
CAR-T (159)
CDC (21)
Cell therapy (429)
Cervical cancer (14)
Clinical research (25135)
Collaboration (725)
Compensation (324)
Complete response letters (15)
COVID-19 (2288)
CRISPR (48)
C-suite (404)
Cystic fibrosis (67)
Data (2618)
Denatured (1)
Depression (25)
Diabetes (150)
Diagnostics (1908)
Digital health (11)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (112)
Drug pricing (21)
Drug shortages (3)
Duchenne muscular dystrophy (98)
Earnings (20409)
Editorial (14)
Employer branding (4)
Employer resources (38)
Events (47770)
Executive appointments (443)
FDA (4814)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (16)
Funding (591)
Gene editing (99)
Generative AI (20)
Gene therapy (370)
GLP-1 (260)
Government (1677)
Guidances (114)
Healthcare (5350)
HIV (44)
Huntington's disease (16)
IgA nephropathy (47)
Immunology and inflammation (87)
Immuno-oncology (21)
Indications (34)
Infectious disease (2502)
Inflammatory bowel disease (89)
Inflation Reduction Act (3)
Influenza (98)
Intellectual property (105)
Interviews (56)
IPO (4731)
IRA (7)
Job creations (909)
Job search strategy (341)
JPM (11)
Kidney cancer (3)
Labor market (25)
Layoffs (94)
Leadership (3)
Legal (1346)
Liver cancer (34)
Longevity (3)
Lung cancer (178)
Lymphoma (187)
Machine learning (20)
Management (12)
Manufacturing (336)
MASH (40)
Medical device (2319)
Medtech (2325)
Mergers & acquisitions (5006)
Metabolic disorders (340)
Multiple sclerosis (81)
NASH (1)
Neurodegenerative disease (104)
Neuropsychiatric disorders (18)
Neuroscience (1032)
Neurotech (1)
NextGen: Class of 2026 (1608)
Non-profit (1235)
Now hiring (15)
Obesity (140)
Opinion (79)
Ovarian cancer (77)
Pain (60)
Pancreatic cancer (120)
Parkinson's disease (123)
Partnered (12)
Patents (189)
Patient recruitment (200)
Peanut (23)
People (21826)
Pharmaceutical (19)
Pharmacy benefit managers (1)
Phase 1 (9281)
Phase 2 (11799)
Phase 3 (7158)
Pipeline (2017)
Policy (59)
Postmarket research (576)
Preclinical (4325)
Press Release (54)
Prostate cancer (72)
Psychedelics (8)
Radiopharmaceuticals (67)
Rare diseases (261)
Real estate (1913)
Recruiting (20)
Regulatory (6594)
Reports (18)
Research institute (849)
Resumes & cover letters (42)
Rett syndrome (11)
RNA editing (7)
RSV (81)
Schizophrenia (30)
Series A (108)
Series B (87)
Service/supplier (4)
Sickle cell disease (33)
Special edition (4)
Spinal muscular atrophy (57)
Sponsored (13)
Startups (1307)
State (1)
Stomach cancer (2)
Supply chain (34)
Tariffs (16)
The Weekly (6)
Vaccines (689)
Venture capital (21)
Weight loss (65)
Women's health (14)
Worklife (4)
Date
Today (17)
Last 7 days (204)
Last 30 days (716)
Last 365 days (11636)
2026 (1059)
2025 (11818)
2024 (13573)
2023 (15078)
2022 (21221)
2021 (26949)
2020 (24460)
2019 (11269)
2018 (8686)
2017 (8750)
2016 (8375)
2015 (9434)
2014 (7256)
2013 (5915)
2012 (6449)
2011 (7131)
2010 (6527)
Location
Africa (315)
Alabama (58)
Alaska (1)
Arizona (60)
Arkansas (7)
Asia (13150)
Australia (2897)
California (4600)
Canada (1208)
China (333)
Colorado (119)
Connecticut (207)
Delaware (107)
Europe (30412)
Florida (583)
Georgia (78)
Hawaii (3)
Idaho (23)
Illinois (256)
India (21)
Indiana (233)
Iowa (7)
Japan (143)
Kansas (25)
Kentucky (7)
Louisiana (6)
Maine (9)
Maryland (561)
Massachusetts (3604)
Michigan (123)
Minnesota (184)
Mississippi (2)
Missouri (27)
Montana (11)
Nebraska (10)
Nevada (38)
New Hampshire (11)
New Jersey (1074)
New Mexico (9)
New York (1123)
North Carolina (627)
North Dakota (6)
Northern California (2263)
Ohio (135)
Oklahoma (10)
Oregon (9)
Pennsylvania (934)
Puerto Rico (10)
Rhode Island (8)
South America (374)
South Carolina (8)
Southern California (1796)
Tennessee (37)
Texas (735)
United States (15707)
Utah (75)
Virginia (120)
Washington D.C. (16)
Washington State (557)
West Virginia (4)
Wisconsin (25)
225,059 Results for "vir biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vir Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
·
1 min read
Press Releases
Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones
January 12, 2026
·
13 min read
Press Releases
Vir Biotechnology to Participate in the Jefferies 2025 London Healthcare Conference
November 10, 2025
·
1 min read
Press Releases
Vir Biotechnology to Participate in the 8th Annual Evercore Healthcare Conference
November 20, 2025
·
1 min read
Press Releases
Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology
December 17, 2025
·
6 min read
Press Releases
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2025 Financial Results
November 5, 2025
·
15 min read
Press Releases
Vir Biotechnology Announces Completion of Enrollment in ECLIPSE 1 Phase 3 Trial for Chronic Hepatitis Delta
November 3, 2025
·
8 min read
Press Releases
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2025 Financial Results on November 5, 2025
October 22, 2025
·
1 min read
Press Releases
Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing Agreement for Ongoing ECLIPSE Clinical Development Program
December 17, 2025
·
9 min read
Press Releases
Vir Biotechnology to Present Week 48 SOLSTICE Clinical Results in Hepatitis Delta at AASLD’s The Liver Meeting® 2025
October 8, 2025
·
3 min read
1 of 22,506
Next
